Literature DB >> 19464294

Differential changes in GPR55 during microglial cell activation.

Maciej Pietr1, Ewa Kozela, Rivka Levy, Neta Rimmerman, Yi Hsing Lin, Nephi Stella, Zvi Vogel, Ana Juknat.   

Abstract

We examined how lipopolysaccharide (LPS) and interferon gamma (IFN-gamma), known to differentially activate microglia, affect the expression of G protein-coupled receptor 55 (GPR55), a novel cannabinoid receptor. We found that GPR55 mRNA is significantly expressed in both primary mouse microglia and the BV-2 mouse microglial cell line, and that LPS down-regulates this message. Conversely, IFN-gamma slightly decreases GPR55 mRNA in primary microglia, while it upregulates this message in BV-2 cells. Moreover, the GPR55 agonist, lysophosphatidylinositol, increases ERK phosphorylation in BV-2 stimulated with IFN-gamma, in correlation with the increased amount of GPR55 mRNA. Remarkably, these stimuli-induced changes in GPR55 expression are similar to those observed with CB(2)-R, suggesting that both receptors might be involved in neuroinflammation and that their expression is concomitantly controlled by the state of microglial activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19464294     DOI: 10.1016/j.febslet.2009.05.028

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  53 in total

Review 1.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

Review 3.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Cannabinoid CB(2) receptors modulate ERK-1/2 kinase signalling and NO release in microglial cells stimulated with bacterial lipopolysaccharide.

Authors:  Stefania Merighi; Stefania Gessi; Katia Varani; Carolina Simioni; Debora Fazzi; Prisco Mirandola; Pier Andrea Borea
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 5.  Endocannabinoids in cerebrovascular regulation.

Authors:  Zoltán Benyó; Éva Ruisanchez; Miriam Leszl-Ishiguro; Péter Sándor; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-29       Impact factor: 4.733

Review 6.  New blood brothers: the GPR55 and CB2 partnership.

Authors:  Andy Irving
Journal:  Cell Res       Date:  2011-05-03       Impact factor: 25.617

7.  Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation.

Authors:  Jeremy D Hill; Viviana Zuluaga-Ramirez; Sachin Gajghate; Malika Winfield; Uma Sriram; Slava Rom; Yuri Persidsky
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

8.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

Review 9.  Cannabinoids and Epilepsy.

Authors:  Evan C Rosenberg; Richard W Tsien; Benjamin J Whalley; Orrin Devinsky
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

10.  N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.

Authors:  Douglas McHugh; Sherry S J Hu; Neta Rimmerman; Ana Juknat; Zvi Vogel; J Michael Walker; Heather B Bradshaw
Journal:  BMC Neurosci       Date:  2010-03-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.